Ivermectin, a new candidate therapeutic against SARS-CoV-2/COVID-19

被引：82
|
作者：
Sharun, Khan [1 ]
Dhama, Kuldeep [2 ]
Patel, Shailesh Kumar [2 ]
Pathak, Mamta [2 ]
Tiwari, Ruchi [3 ]
Singh, Bhoj Raj [4 ]
Sah, Ranjit [5 ]
Bonilla-Aldana, D. Katterine [6 ,7 ]
Rodriguez-Morales, Alfonso J. [7 ,8 ]
Leblebicioglu, Hakan [9 ]
机构：
[1] ICAR Indian Vet Res Inst, Div Surg, Bareilly 243122, Uttar Pradesh, India
[2] ICAR Indian Vet Res Inst, Div Pathol, Bareilly 243122, Uttar Pradesh, India
[3] UP Pandit Deen Dayal Upadhayay Pashu Chikitsa Vig, Dept Vet Microbiol & Immunol, Coll Vet Sci, Mathura 281001, India
[4] ICAR Indian Vet Res Inst, Div Epidemiol, Bareilly 243122, Uttar Pradesh, India
[5] Tribhuvan Univ Teaching Hosp, Inst Med, Dept Microbiol, Kathmandu, Nepal
[6] Fdn Univ Autonoma Amer, Semillero Zoonosis, Grp Invest BIOECOS, Sede Pereira, Pereira, Risaralda, Colombia
[7] Univ Tecnol Pereira, Publ Hlth & Infect Res Grp, Fac Hlth Sci, Pereira, Colombia
[8] Fdn Univ Autonoma Amer, Fac Med, Grp Invest Biomed, Pereira, Risaralda, Colombia
[9] Samsun Liv Hosp, Dept Infect Dis, Samsun, Turkey
来源：
ANNALS OF CLINICAL MICROBIOLOGY AND ANTIMICROBIALS | 2020年 / 19卷 / 01期
关键词：
COVID-19; 2019-nCoV; SARS-CoV-2; Coronavirus; Therapeutics; Ivermectin; NUCLEAR IMPORT; WONDER DRUG; VIRUS; REPLICATION; INHIBITORS;
D O I：
10.1186/s12941-020-00368-w
中图分类号：
Q93 [微生物学];
学科分类号：
071005 ; 100705 ;
摘要：
引用
收藏
页数：5
相关论文
共 50 条
  • [41] An update on drugs with therapeutic potential for SARS-CoV-2 (COVID-19) treatment
    Drozdzal, Sylwester
    Rosik, Jakub
    Lechowicz, Kacper
    Machaj, Filip
    Szostak, Bartosz
    Przybycinski, Jaroslaw
    Lorzadeh, Shahrokh
    Kotfis, Katarzyna
    Ghavami, Saeid
    Los, Marek J.
    DRUG RESISTANCE UPDATES, 2021, 59
  • [42] Challenges for Targeting SARS-CoV-2 Proteases as a Therapeutic Strategy for COVID-19
    Steuten, Kas
    Kim, Heeyoung
    Widen, John C.
    Babin, Brett M.
    Onguka, Ouma
    Lovell, Scott
    Bolgi, Oguz
    Cerikan, Berati
    Neufeldt, Christopher J.
    Cortese, Mirko
    Muir, Ryan K.
    Bennett, John M.
    Geiss-Friedlander, Ruth
    Peters, Christoph
    Bartenschlager, Ralf
    Bogyo, Matthew
    ACS INFECTIOUS DISEASES, 2021, 7 (06): : 1457 - 1468
  • [43] Naringerin as candidate drug against SARS-CoV-2: The role for TPC2 genomic variants in COVID-19
    Di Maria, Emilio
    Martini, Paolo
    Gennarelli, Massimo
    PHARMACOLOGICAL RESEARCH, 2021, 164
  • [44] An oral SARS-CoV-2 Mpro inhibitor clinical candidate for the treatment of COVID-19
    Owen, Dafydd R.
    Allerton, Charlotte M. N.
    Anderson, Annaliesa S.
    Aschenbrenner, Lisa
    Avery, Melissa
    Berritt, Simon
    Boras, Britton
    Cardin, Rhonda D.
    Carlo, Anthony
    Coffman, Karen J.
    Dantonio, Alyssa
    Di, Li
    Eng, Heather
    Ferre, RoseAnn
    Gajiwala, Ketan S.
    Gibson, Scott A.
    Greasley, Samantha E.
    Hurst, Brett L.
    Kadar, Eugene P.
    Kalgutkar, Amit S.
    Lee, Jack C.
    Lee, Jisun
    Liu, Wei
    Mason, Stephen W.
    Noell, Stephen
    Novak, Jonathan J.
    Obach, R. Scott
    Ogilvie, Kevin
    Patel, Nandini C.
    Pettersson, Martin
    Rai, Devendra K.
    Reese, Matthew R.
    Sammons, Matthew F.
    Sathish, Jean G.
    Singh, Ravi Shankar P.
    Steppan, Claire M.
    Stewart, Al E.
    Tuttle, Jamison B.
    Updyke, Lawrence
    Verhoest, Patrick R.
    Wei, Liuqing
    Yang, Qingyi
    Zhu, Yuao
    SCIENCE, 2021, 374 (6575) : 1586 - +
  • [45] Persistence of SARS-CoV-2: a new paradigm of COVID-19 management
    Alhusseini, L. B.
    Yassen, L. T.
    Kouhsari, E.
    Al Marjani, M. F.
    ANNALI DI IGIENE MEDICINA PREVENTIVA E DI COMUNITA, 2021, 33 (05): : 426 - 432
  • [46] COVID-19: The New Ultrasound Alphabet in SARS-CoV-2 Era
    Anile, Antonio
    Castiglione, Giacomo
    Zangara, Chiara
    Calabro, Chiara
    Vaccaro, Mauro
    Sorbello, Massimiliano
    ANESTHESIA AND ANALGESIA, 2020, 131 (05): : E232 - E234
  • [47] SARS-CoV-2 (COVID-19): New Discoveries and Current Challenges
    Soufi, Ghazaleh Jamalipour
    Hekmatnia, Ali
    Nasrollahzadeh, Mahmoud
    Shafiei, Nasrin
    Sajjadi, Mohaddeseh
    Iravani, Parisa
    Fallah, Salman
    Iravani, Siavash
    Varma, Rajender S.
    APPLIED SCIENCES-BASEL, 2020, 10 (10):
  • [48] SARS-CoV-2 (COVID-19): Beginning to Understand a New Virus
    Van Vo, Giau
    Bagyinszky, Eva
    Park, Yoon Soo
    Hulme, John
    An, Seong Soo A.
    CLINICAL, BIOLOGICAL AND MOLECULAR ASPECTS OF COVID-19, 2021, 1321 : 3 - 19
  • [49] Hydroxychloroquine in COVID-19: Potential Mechanism of Action Against SARS-CoV-2
    Satarker S.
    Ahuja T.
    Banerjee M.
    E V.B.
    Dogra S.
    Agarwal T.
    Nampoothiri M.
    Current Pharmacology Reports, 2020, 6 (5) : 203 - 211
  • [50] The global battle against SARS-CoV-2 and COVID-19 at the third year
    Deng, Chu-Xia
    INTERNATIONAL JOURNAL OF BIOLOGICAL SCIENCES, 2022, 18 (12): : 4792 - 4794
12345